enVVeno Medical Corporation Common Stock (NVNO)
Stock · NASDAQ · Health Care
$7.47as of 10/16/2026
Price chart
Active signals
NVNO Signal Track Record
How signals performed across all stocks →What NVNO's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakout | 21 | -3.4% | 43% | August 17, 2026 |
| 200-Day Moving Average TouchActive now | 19 | +3.8% | 53% | September 3, 2026 |
| Bollinger Band Breakdown | 17 | -2.6% | 47% | September 14, 2026 |
| Volume SpikeActive now | 11 | -3.8% | 36% | September 30, 2026 |
| Any 20-session window (baseline) | -2.5% | 44% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About NVNO
enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an ope…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 33
- Website
- envveno.com/
Fundamentals
- 1-day range
- $7.35$7.93
- Market cap
- $6.93M
- P/E (trailing)
- —
- P/E (forward)
- -1.27
- EPS (trailing)
- $-25.19
- Dividend yield
- —
- Beta
- 1.36
- Avg. volume
- 25.2K
- Dividend pay date
- November 30, 2020
How enVVeno Medical Corporation Common Stock Makes Money
Where the revenue actually goes — FY2019 annual results
Source: 10-K filed Mar 18, 2020 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
enVVeno Medical Corporation Common Stock Competitors
Chosen by industry and closest market cap.
- NVNOenVVeno Medical Corporation Common Stock$7.47▼ 5.74%Market cap $6.93MP/E —$7.01$30.8
- PMIPicard Medical Inc. Common Stock$12.75▲ 27.50%Market cap $7.27MP/E —$2.65$684
- SNOASonoma Pharmaceuticals Inc. Common Stock$1.12▼ 2.61%Market cap $5.99MP/E —$0.8501$4.25
- FEMYFemasys Inc. Common Stock$1.65▼ 4.90%Market cap $8.91MP/E —$1.67$22.2
- XAIRBeyond Air Inc. Common Stock$2.16▼ 2.26%Market cap $4.93MP/E —$2.31$55.6
- INBSIntelligent Bio Solutions Inc. Common Stock$1.5▲ 4.17%Market cap $4.76MP/E —$1.35$24.9
- VVOSVivos Therapeutics Inc. Common Stock$0.131▼ 8.39%Market cap $4.47MP/E —$0.1276$3.28
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| NVNO enVVeno Medical Corporation Common Stock | $6.93M | — | $7.47 | ▼ 5.74% | $7.01$30.8 |
| PMI Picard Medical Inc. Common Stock | $7.27M | — | $12.75 | ▲ 27.50% | $2.65$684 |
| SNOA Sonoma Pharmaceuticals Inc. Common Stock | $5.99M | — | $1.12 | ▼ 2.61% | $0.8501$4.25 |
| FEMY Femasys Inc. Common Stock | $8.91M | — | $1.65 | ▼ 4.90% | $1.67$22.2 |
| XAIR Beyond Air Inc. Common Stock | $4.93M | — | $2.16 | ▼ 2.26% | $2.31$55.6 |
| INBS Intelligent Bio Solutions Inc. Common Stock | $4.76M | — | $1.5 | ▲ 4.17% | $1.35$24.9 |
| VVOS Vivos Therapeutics Inc. Common Stock | $4.47M | — | $0.131 | ▼ 8.39% | $0.1276$3.28 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- enVVeno Medical's First-in-Class enVVe System to Be Featured at The VEINS 2026 Innovation Summit as Company Advances Toward U.S. Pivotal TrialYahoo · 10/2/2026
- enVVeno Medical CEO Rob Berman Goes Direct to Investors with New "WTF" Video SeriesYahoo · 9/16/2026
- enVVeno Medical Presentation from H.C. Wainwright Conference Now Available On-DemandYahoo · 9/11/2026
Insider Activity
Insider Actions →- Francis Duhay · September 11, 2026 · Sale11 @ $11.21
- Francis Duhay · June 11, 2026 · Sale140 @ $10.31
Institutional Ownership
March 31, 2026
- Total shares held
- 93.0K
- Total value held
- $942.5K
- Institutional holders
- 14
- Unknown36.2K
- Unknown35.7K
- Unknown10.5K
- Unknown6.3K
- Unknown1.8K
- Unknown1.6K
- Unknown542
- Unknown243
- Unknown114
- Unknown76
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
enVVeno Medical to Showcase enVVe System at VEINS 2026 Summit
enVVeno Medical Corporation announced that its first-in-class enVVe system will be featured at The VEINS 2026 Innovation Summit. This event highlights the company's progress as it moves toward a U.S. pivotal trial for its medical technology. The announcement serves as a key milestone in the development timeline for the device.
enVVeno Medical to Showcase enVVe System at VEINS 2026 Summit. enVVeno Medical Corporation announced that its first-in-class enVVe system will be featured at The VEINS 2026 Innovation Summit. This event highlights the company's progress as it moves toward a U.S. pivotal trial for its medical technology. The announcement serves as a key milestone in the development timeline for the device.